OGJ
(2S)-2-(4-{2-[3-(fluoromethyl)azetidin-1-yl]ethoxy}phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-1-benzopyran-6-ol
Find entries where: OGJ
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
|---|---|
| Name | (2S)-2-(4-{2-[3-(fluoromethyl)azetidin-1-yl]ethoxy}phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-1-benzopyran-6-ol |
| Identifiers | (2~{S})-2-[4-[2-[3-(fluoranylmethyl)azetidin-1-yl]ethoxy]phenyl]-3-(3-hydroxyphenyl)-4-methyl-2~{H}-chromen-6-ol |
| Formula | C28 H28 F N O4 |
| Molecular Weight | 461.525 |
| Type | NON-POLYMER |
| Isomeric SMILES | CC1=C([C@@H](Oc2c1cc(cc2)O)c3ccc(cc3)OCCN4CC(C4)CF)c5cccc(c5)O |
| InChI | InChI=1S/C28H28FNO4/c1-18-25-14-23(32)7-10-26(25)34-28(27(18)21-3-2-4-22(31)13-21)20-5-8-24(9-6-20)33-12-11-30-16-19(15-29)17-30/h2-10,13-14,19,28,31-32H,11-12,15-17H2,1H3/t28-/m0/s1 |
| InChIKey | KJAAPZIFCQQQKX-NDEPHWFRSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 62 |
| Chiral Atom Count | 1 |
| Bond Count | 66 |
| Aromatic Bond Count | 18 |
Drug Info: DrugBank
| DrugBank ID | DB14934 |
|---|---|
| Name | GDC-0927 |
| Groups | investigational |
| Description | GDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer). |
| Synonyms | GDC-0927 |
| CAS number | 2100830-77-9 |
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 87055263 |
